Vanja de Weerd

2.2k total citations
44 papers, 1.4k citations indexed

About

Vanja de Weerd is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, Vanja de Weerd has authored 44 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Cancer Research, 18 papers in Molecular Biology and 18 papers in Oncology. Recurrent topics in Vanja de Weerd's work include Cancer Genomics and Diagnostics (21 papers), Cancer-related molecular mechanisms research (8 papers) and Genetic factors in colorectal cancer (7 papers). Vanja de Weerd is often cited by papers focused on Cancer Genomics and Diagnostics (21 papers), Cancer-related molecular mechanisms research (8 papers) and Genetic factors in colorectal cancer (7 papers). Vanja de Weerd collaborates with scholars based in Netherlands, Spain and United States. Vanja de Weerd's co-authors include Anieta M. Sieuwerts, John W.M. Martens, John A. Foekens, Marcel Smid, Maxime P. Look, Jan G.M. Klijn, Erik A.C. Wiemer, Antonius W.M. Boersma, Stefan Sleijfer and Marion E. Meijer‐van Gelder and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Medicine and Journal of Clinical Oncology.

In The Last Decade

Vanja de Weerd

42 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Vanja de Weerd Netherlands	17	892	890	401	182	112	44	1.4k
David C. Corney United States	13	1.2k 1.4×	932 1.0×	288 0.7×	212 1.2×	81 0.7×	17	1.6k
Einav Nili Gal‐Yam Israel	16	1.2k 1.4×	344 0.4×	317 0.8×	155 0.9×	282 2.5×	53	1.6k
Kalpana Ramnarayanan Singapore	9	1.1k 1.2×	724 0.8×	138 0.3×	120 0.7×	85 0.8×	10	1.4k
Kaitlyn A. Webster United States	13	1.7k 1.9×	970 1.1×	262 0.7×	125 0.7×	331 3.0×	16	2.2k
Yannick Saintigny France	21	1.2k 1.4×	373 0.4×	644 1.6×	208 1.1×	87 0.8×	35	1.6k
Claire Attwooll United States	9	961 1.1×	259 0.3×	375 0.9×	144 0.8×	170 1.5×	12	1.3k
Nathalie Meyer‐Schaller Switzerland	17	1.2k 1.3×	399 0.4×	494 1.2×	116 0.6×	128 1.1×	21	1.5k
Natalie Meyer Canada	5	1.2k 1.3×	337 0.4×	351 0.9×	82 0.5×	66 0.6×	7	1.5k
Björn Bakker Netherlands	19	974 1.1×	432 0.5×	377 0.9×	60 0.3×	266 2.4×	27	1.4k
Alice H. Berger United States	13	719 0.8×	219 0.2×	239 0.6×	145 0.8×	124 1.1×	23	1.0k

Countries citing papers authored by Vanja de Weerd

Since Specialization

Citations

This map shows the geographic impact of Vanja de Weerd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vanja de Weerd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vanja de Weerd more than expected).

Fields of papers citing papers by Vanja de Weerd

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vanja de Weerd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vanja de Weerd. The network helps show where Vanja de Weerd may publish in the future.

Co-authorship network of co-authors of Vanja de Weerd

This figure shows the co-authorship network connecting the top 25 collaborators of Vanja de Weerd. A scholar is included among the top collaborators of Vanja de Weerd based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vanja de Weerd. Vanja de Weerd is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jongbloed, Elisabeth M., Vanja de Weerd, Corine M. Beaufort, et al.. (2025). Early versus deferred use of CDK4/6 inhibitors in advanced breast cancer: circulating tumor DNA analysis of a randomized phase 3 trial. Nature Medicine. 31(11). 3662–3667. 2 indexed citations

Fu, Siyu, Ruben Boers, Joachim Boers, et al.. (2025). Genome-Wide Methylation Sequencing to Identify DNA Methylation Markers for Early-stage Hepatocellular Carcinoma in Liver and Blood. Journal of Experimental & Clinical Cancer Research. 44(1). 144–144.

Dessel, Lisanne F. van, Vanja de Weerd, Corine M. Beaufort, et al.. (2025). Cell‐free DNA aneuploidy score as a dynamic early response marker in prostate cancer. Molecular Oncology. 19(10). 2822–2832. 1 indexed citations

Jongbloed, Elisabeth M., Maurice P.H.M. Jansen, Vanja de Weerd, et al.. (2023). Machine learning-based somatic variant calling in cell-free DNA of metastatic breast cancer patients using large NGS panels. Scientific Reports. 13(1). 10424–10424. 2 indexed citations

Mostert, Bianca, Jaco Kraan, Vanja de Weerd, et al.. (2023). mFast‐SeqS‐based aneuploidy score in circulating cell‐free DNA is a prognostic biomarker in prostate cancer. Molecular Oncology. 17(9). 1898–1907. 5 indexed citations

Weerd, Vanja de, Jaco Kraan, John W.M. Martens, et al.. (2023). Liquid Biopsies for Early Response Evaluation of Radium-223 in Metastatic Prostate Cancer. JCO Precision Oncology. 7(7). e2300156–e2300156. 1 indexed citations

Weerd, Vanja de, Mai N. Van, Jaco Kraan, et al.. (2023). Tumor-agnostic ctDNA levels by mFAST-SeqS in first-line HR-positive, HER2 negative metastatic breast cancer patients as a biomarker for survival. npj Breast Cancer. 9(1). 61–61. 6 indexed citations

Robbrecht, Debbie, Ronald de Wit, Vanja de Weerd, et al.. (2022). Genome‐wide aneuploidy detected by mFast‐SeqS in circulating cell‐free DNA is associated with poor response to pembrolizumab in patients with advanced urothelial cancer. Molecular Oncology. 16(10). 2086–2097. 14 indexed citations

Smid, Marcel, Robert R.J. Coebergh van den Braak, Carolien H. M. van Deurzen, et al.. (2021). Circular RNA in Chemonaive Lymph Node Negative Colon Cancer Patients. Cancers. 13(8). 1903–1903. 2 indexed citations

10.

Angus, Lindsay, Agnes Jager, John W.M. Martens, et al.. (2021). Detection of Aneuploidy in Cerebrospinal Fluid from Patients with Breast Cancer Can Improve Diagnosis of Leptomeningeal Metastases. Clinical Cancer Research. 27(10). 2798–2806. 22 indexed citations

11.

Sieuwerts, Anieta M., Willemijne A.M.E. Schrijver, Simone U. Dalm, et al.. (2017). Progressive APOBEC3B mRNA expression in distant breast cancer metastases. PLoS ONE. 12(1). e0171343–e0171343. 27 indexed citations

12.

Sieuwerts, Anieta M., et al.. (2017). Gene Expression Differences between Ductal Carcinoma in Situ with and without Progression to Invasive Breast Cancer. American Journal Of Pathology. 187(7). 1648–1655. 25 indexed citations

13.

Dalm, Simone U., Willemijne A.M.E. Schrijver, Anieta M. Sieuwerts, et al.. (2017). Prospects of Targeting the Gastrin Releasing Peptide Receptor and Somatostatin Receptor 2 for Nuclear Imaging and Therapy in Metastatic Breast Cancer. PLoS ONE. 12(1). e0170536–e0170536. 10 indexed citations

14.

Mostert, Bianca, Anieta M. Sieuwerts, Joan Bolt‐de Vries, et al.. (2015). mRNA expression profiles in circulating tumor cells of metastatic colorectal cancer patients. Molecular Oncology. 9(4). 920–932. 39 indexed citations

15.

Ansems, Marleen, Jonas Nørskov Søndergaard, Anieta M. Sieuwerts, et al.. (2015). DC-SCRIPT is a novel regulator of the tumor suppressor gene CDKN2B and induces cell cycle arrest in ERα-positive breast cancer cells. Breast Cancer Research and Treatment. 149(3). 693–703. 10 indexed citations

16.

Mustafa, Dana A. M., Anieta M. Sieuwerts, Marcel Smid, et al.. (2014). BM-22 * BOC AND MAP2 ARE OPERATIVE IN BREAST CANCER METASTASIS TO BRAIN. Neuro-Oncology. 16(suppl 5). v36–v37. 1 indexed citations

17.

Riaz, Muhammad, Els M.J.J. Berns, Anieta M. Sieuwerts, et al.. (2011). Correlation of breast cancer susceptibility loci with patient characteristics, metastasis-free survival, and mRNA expression of the nearest genes. Breast Cancer Research and Treatment. 133(3). 843–851. 46 indexed citations

18.

Nagel, Jord H.A., Justine Peeters, Marcel Smid, et al.. (2011). Gene expression profiling assigns CHEK2 1100delC breast cancers to the luminal intrinsic subtypes. Breast Cancer Research and Treatment. 132(2). 439–448. 28 indexed citations

19.

Sieuwerts, Anieta M., Anne van Galen, Helenius J. Kloosterboer, et al.. (2011). Hormone replacement therapy dependent changes in breast cancer‐related gene expression in breast tissue of healthy postmenopausal women. Molecular Oncology. 5(6). 504–516. 5 indexed citations

20.

Rodríguez-González, F. Germán, Anieta M. Sieuwerts, Marcel Smid, et al.. (2010). MicroRNA-30c expression level is an independent predictor of clinical benefit of endocrine therapy in advanced estrogen receptor positive breast cancer. Breast Cancer Research and Treatment. 127(1). 43–51. 116 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact